4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · IEX Real-Time Price · USD
18.35
-0.17 (-0.92%)
Jul 26, 2024, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Employees
4D Molecular Therapeutics had 147 employees as of December 31, 2023. The number of employees increased by 7 or 5.00% compared to the previous year.
Employees
147
Change (1Y)
7
Growth (1Y)
5.00%
Revenue / Employee
$139,129
Profits / Employee
-$711,265
Market Cap
948.76M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 147 | 7 | 5.00% |
Dec 31, 2022 | 140 | 16 | 12.90% |
Dec 31, 2021 | 124 | 41 | 49.40% |
Dec 31, 2020 | 83 | 26 | 45.61% |
Jun 30, 2019 | 57 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Embecta | 2,200 |
HealthStream | 1,092 |
Pacira BioSciences | 712 |
CareDx | 643 |
Cronos Group | 356 |
Humacyte | 185 |
Pharvaris | 82 |
89bio | 70 |
FDMT News
- 4 hours ago - 4D Molecular Therapeutics, Inc. (FDMT) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire
- 5 hours ago - The Schall Law Firm Invites FDMT Investors To Participate In The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc. - Accesswire
- 10 hours ago - Investors who lost money on 4D Molecular Therapeutics, Inc. should contact Levi & Korsinsky about an ongoing investigation - FDMT - Accesswire
- 10 hours ago - FDMT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into 4D Molecular Therapeutics, Inc. and Encourages Stockholders to Contact the Firm! - Accesswire
- 1 day ago - An Investigation Has Commenced on Behalf of 4D Molecular Therapeutics, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your FDMT Losses. - Accesswire
- 1 day ago - 4D Molecular Therapeutics, Inc. (FDMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - GlobeNewsWire
- 1 day ago - The Schall Law Firm Invites FDMT Investors To Join The Securities Fraud Investigation Of 4D Molecular Therapeutics Inc. - Accesswire
- 1 day ago - FDMT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of 4D Molecular Therapeutics, Inc. Shareholders Who Lost Money - Accesswire